139 related articles for article (PubMed ID: 6740736)
1. Use of plasma unbound drug concentrations in adjusting phenytoin doses.
Bachmann K; Voeller K; Forney R
Ther Drug Monit; 1984; 6(2):173-8. PubMed ID: 6740736
[TBL] [Abstract][Full Text] [Related]
2. A new approach to establishing individualized maintenance doses of phenytoin.
Bachmann K; Sullivan TJ; Schwartz J; Jauregui L
Ther Drug Monit; 1985; 7(4):391-400. PubMed ID: 4082238
[TBL] [Abstract][Full Text] [Related]
3. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
[TBL] [Abstract][Full Text] [Related]
4. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
[TBL] [Abstract][Full Text] [Related]
5. In vivo binding characteristics of phenytoin to serum proteins in monotherapy for adults with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Am J Ther; 2000 Nov; 7(6):359-63. PubMed ID: 11304643
[TBL] [Abstract][Full Text] [Related]
6. Clinical rules for phenytoin dosing.
Privitera MD
Ann Pharmacother; 1993 Oct; 27(10):1169-73. PubMed ID: 7818614
[TBL] [Abstract][Full Text] [Related]
7. Effect of temperature on binding characteristics of phenytoin to serum proteins in monotherapy adult patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Am J Ther; 2000 Jan; 7(1):11-5. PubMed ID: 11319568
[TBL] [Abstract][Full Text] [Related]
8. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
[TBL] [Abstract][Full Text] [Related]
9. Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid.
Haidukewych D; Rodin EA; Zielinski JJ
Ther Drug Monit; 1989; 11(2):134-9. PubMed ID: 2497562
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein binding of phenytoin in 100 epileptic patients.
Peterson GM; McLean S; Aldous S; Von Witt RJ; Millingen KS
Br J Clin Pharmacol; 1982 Aug; 14(2):298-300. PubMed ID: 7104186
[TBL] [Abstract][Full Text] [Related]
11. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
12. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic profile of a 300-mg extended phenytoin sodium capsule (Dilantin) formulation.
Randinitis EJ; Buchanan RA; Kinkel AW
Epilepsia; 1990; 31(4):458-64. PubMed ID: 2369880
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent interaction between phenytoin and valproic acid.
Riva R; Albani F; Contin M; Perucca E; Ambrosetto G; Gobbi G; Santucci M; Procaccianti G; Baruzzi A
Neurology; 1985 Apr; 35(4):510-5. PubMed ID: 3920548
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
Zielinski JJ; Haidukewych D; Leheta BJ
Ther Drug Monit; 1985; 7(1):51-3. PubMed ID: 3992622
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of unbound phenytoin in the management of epilepsy.
Kilpatrick CJ; Wanwimolruk S; Wing LM
Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
[TBL] [Abstract][Full Text] [Related]
17. Effect of acute and chronic terfenadine on free and total serum phenytoin concentrations in epileptic patients.
Coniglio AA; Garnett WR; Pellock JH; Tsidonis O; Hepler CD; Serafin R; Small RE; Driscoll SM; Karnes HT
Epilepsia; 1989; 30(5):611-6. PubMed ID: 2571498
[TBL] [Abstract][Full Text] [Related]
18. Phenytoin/clonazepam interaction.
Saavedra IN; Aguilera LI; Faure E; Galdames DG
Ther Drug Monit; 1985; 7(4):481-4. PubMed ID: 4082246
[TBL] [Abstract][Full Text] [Related]
19. Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients.
Privitera MD
Ther Drug Monit; 1989 Nov; 11(6):647-51. PubMed ID: 2595745
[TBL] [Abstract][Full Text] [Related]
20. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
May T; Rambeck B
Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
